Global Alzheimer's Disease Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Alzheimer's Disease Drug market size was valued at USD 3722.7 million in 2023 and is forecast to a readjusted size of USD 4113.3 million by 2030 with a CAGR of 1.4% during review period.

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

The Global Info Research report includes an overview of the development of the Alzheimer's Disease Drug industry chain, the market status of Early to Moderate Stages (Donepezil, Memantine), Moderate to Severe Stages (Donepezil, Memantine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Alzheimer's Disease Drug.

Regionally, the report analyzes the Alzheimer's Disease Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Alzheimer's Disease Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Alzheimer's Disease Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Alzheimer's Disease Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Donepezil, Memantine).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Alzheimer's Disease Drug market.

Regional Analysis: The report involves examining the Alzheimer's Disease Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Alzheimer's Disease Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Alzheimer's Disease Drug:
Company Analysis: Report covers individual Alzheimer's Disease Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Alzheimer's Disease Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Early to Moderate Stages, Moderate to Severe Stages).

Technology Analysis: Report covers specific technologies relevant to Alzheimer's Disease Drug. It assesses the current state, advancements, and potential future developments in Alzheimer's Disease Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Alzheimer's Disease Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Alzheimer's Disease Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Donepezil
    Memantine
    Rivastigmine
    Others

Market segment by Application
    Early to Moderate Stages
    Moderate to Severe Stages

Major players covered
    Allergan
    Eisai
    Novartis
    Daiichi Sankyo
    Merz Pharma
    Pfizer
    Johnson & Johnson
    Lundbeck

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer's Disease Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Alzheimer's Disease Drug, with price, sales, revenue and global market share of Alzheimer's Disease Drug from 2019 to 2024.
Chapter 3, the Alzheimer's Disease Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer's Disease Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Alzheimer's Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Alzheimer's Disease Drug.
Chapter 14 and 15, to describe Alzheimer's Disease Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Alzheimer's Disease Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Alzheimer's Disease Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Donepezil
        1.3.3 Memantine
        1.3.4 Rivastigmine
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Alzheimer's Disease Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Early to Moderate Stages
        1.4.3 Moderate to Severe Stages
    1.5 Global Alzheimer's Disease Drug Market Size & Forecast
        1.5.1 Global Alzheimer's Disease Drug Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Alzheimer's Disease Drug Sales Quantity (2019-2030)
        1.5.3 Global Alzheimer's Disease Drug Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Allergan
        2.1.1 Allergan Details
        2.1.2 Allergan Major Business
        2.1.3 Allergan Alzheimer's Disease Drug Product and Services
        2.1.4 Allergan Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Allergan Recent Developments/Updates
    2.2 Eisai
        2.2.1 Eisai Details
        2.2.2 Eisai Major Business
        2.2.3 Eisai Alzheimer's Disease Drug Product and Services
        2.2.4 Eisai Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Eisai Recent Developments/Updates
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Alzheimer's Disease Drug Product and Services
        2.3.4 Novartis Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Novartis Recent Developments/Updates
    2.4 Daiichi Sankyo
        2.4.1 Daiichi Sankyo Details
        2.4.2 Daiichi Sankyo Major Business
        2.4.3 Daiichi Sankyo Alzheimer's Disease Drug Product and Services
        2.4.4 Daiichi Sankyo Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Daiichi Sankyo Recent Developments/Updates
    2.5 Merz Pharma
        2.5.1 Merz Pharma Details
        2.5.2 Merz Pharma Major Business
        2.5.3 Merz Pharma Alzheimer's Disease Drug Product and Services
        2.5.4 Merz Pharma Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Merz Pharma Recent Developments/Updates
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Alzheimer's Disease Drug Product and Services
        2.6.4 Pfizer Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Pfizer Recent Developments/Updates
    2.7 Johnson & Johnson
        2.7.1 Johnson & Johnson Details
        2.7.2 Johnson & Johnson Major Business
        2.7.3 Johnson & Johnson Alzheimer's Disease Drug Product and Services
        2.7.4 Johnson & Johnson Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Johnson & Johnson Recent Developments/Updates
    2.8 Lundbeck
        2.8.1 Lundbeck Details
        2.8.2 Lundbeck Major Business
        2.8.3 Lundbeck Alzheimer's Disease Drug Product and Services
        2.8.4 Lundbeck Alzheimer's Disease Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Lundbeck Recent Developments/Updates

3 Competitive Environment: Alzheimer's Disease Drug by Manufacturer
    3.1 Global Alzheimer's Disease Drug Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Alzheimer's Disease Drug Revenue by Manufacturer (2019-2024)
    3.3 Global Alzheimer's Disease Drug Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Alzheimer's Disease Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Alzheimer's Disease Drug Manufacturer Market Share in 2023
        3.4.2 Top 6 Alzheimer's Disease Drug Manufacturer Market Share in 2023
    3.5 Alzheimer's Disease Drug Market: Overall Company Footprint Analysis
        3.5.1 Alzheimer's Disease Drug Market: Region Footprint
        3.5.2 Alzheimer's Disease Drug Market: Company Product Type Footprint
        3.5.3 Alzheimer's Disease Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Alzheimer's Disease Drug Market Size by Region
        4.1.1 Global Alzheimer's Disease Drug Sales Quantity by Region (2019-2030)
        4.1.2 Global Alzheimer's Disease Drug Consumption Value by Region (2019-2030)
        4.1.3 Global Alzheimer's Disease Drug Average Price by Region (2019-2030)
    4.2 North America Alzheimer's Disease Drug Consumption Value (2019-2030)
    4.3 Europe Alzheimer's Disease Drug Consumption Value (2019-2030)
    4.4 Asia-Pacific Alzheimer's Disease Drug Consumption Value (2019-2030)
    4.5 South America Alzheimer's Disease Drug Consumption Value (2019-2030)
    4.6 Middle East and Africa Alzheimer's Disease Drug Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Alzheimer's Disease Drug Sales Quantity by Type (2019-2030)
    5.2 Global Alzheimer's Disease Drug Consumption Value by Type (2019-2030)
    5.3 Global Alzheimer's Disease Drug Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Alzheimer's Disease Drug Sales Quantity by Application (2019-2030)
    6.2 Global Alzheimer's Disease Drug Consumption Value by Application (2019-2030)
    6.3 Global Alzheimer's Disease Drug Average Price by Application (2019-2030)

7 North America
    7.1 North America Alzheimer's Disease Drug Sales Quantity by Type (2019-2030)
    7.2 North America Alzheimer's Disease Drug Sales Quantity by Application (2019-2030)
    7.3 North America Alzheimer's Disease Drug Market Size by Country
        7.3.1 North America Alzheimer's Disease Drug Sales Quantity by Country (2019-2030)
        7.3.2 North America Alzheimer's Disease Drug Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Alzheimer's Disease Drug Sales Quantity by Type (2019-2030)
    8.2 Europe Alzheimer's Disease Drug Sales Quantity by Application (2019-2030)
    8.3 Europe Alzheimer's Disease Drug Market Size by Country
        8.3.1 Europe Alzheimer's Disease Drug Sales Quantity by Country (2019-2030)
        8.3.2 Europe Alzheimer's Disease Drug Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Alzheimer's Disease Drug Market Size by Region
        9.3.1 Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Alzheimer's Disease Drug Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Alzheimer's Disease Drug Sales Quantity by Type (2019-2030)
    10.2 South America Alzheimer's Disease Drug Sales Quantity by Application (2019-2030)
    10.3 South America Alzheimer's Disease Drug Market Size by Country
        10.3.1 South America Alzheimer's Disease Drug Sales Quantity by Country (2019-2030)
        10.3.2 South America Alzheimer's Disease Drug Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Alzheimer's Disease Drug Market Size by Country
        11.3.1 Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Alzheimer's Disease Drug Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Alzheimer's Disease Drug Market Drivers
    12.2 Alzheimer's Disease Drug Market Restraints
    12.3 Alzheimer's Disease Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Alzheimer's Disease Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Alzheimer's Disease Drug
    13.3 Alzheimer's Disease Drug Production Process
    13.4 Alzheimer's Disease Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Alzheimer's Disease Drug Typical Distributors
    14.3 Alzheimer's Disease Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Alzheimer's Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Alzheimer's Disease Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Allergan Basic Information, Manufacturing Base and Competitors
    Table 4. Allergan Major Business
    Table 5. Allergan Alzheimer's Disease Drug Product and Services
    Table 6. Allergan Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Allergan Recent Developments/Updates
    Table 8. Eisai Basic Information, Manufacturing Base and Competitors
    Table 9. Eisai Major Business
    Table 10. Eisai Alzheimer's Disease Drug Product and Services
    Table 11. Eisai Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Eisai Recent Developments/Updates
    Table 13. Novartis Basic Information, Manufacturing Base and Competitors
    Table 14. Novartis Major Business
    Table 15. Novartis Alzheimer's Disease Drug Product and Services
    Table 16. Novartis Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Novartis Recent Developments/Updates
    Table 18. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
    Table 19. Daiichi Sankyo Major Business
    Table 20. Daiichi Sankyo Alzheimer's Disease Drug Product and Services
    Table 21. Daiichi Sankyo Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Daiichi Sankyo Recent Developments/Updates
    Table 23. Merz Pharma Basic Information, Manufacturing Base and Competitors
    Table 24. Merz Pharma Major Business
    Table 25. Merz Pharma Alzheimer's Disease Drug Product and Services
    Table 26. Merz Pharma Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Merz Pharma Recent Developments/Updates
    Table 28. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 29. Pfizer Major Business
    Table 30. Pfizer Alzheimer's Disease Drug Product and Services
    Table 31. Pfizer Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Pfizer Recent Developments/Updates
    Table 33. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 34. Johnson & Johnson Major Business
    Table 35. Johnson & Johnson Alzheimer's Disease Drug Product and Services
    Table 36. Johnson & Johnson Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Johnson & Johnson Recent Developments/Updates
    Table 38. Lundbeck Basic Information, Manufacturing Base and Competitors
    Table 39. Lundbeck Major Business
    Table 40. Lundbeck Alzheimer's Disease Drug Product and Services
    Table 41. Lundbeck Alzheimer's Disease Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Lundbeck Recent Developments/Updates
    Table 43. Global Alzheimer's Disease Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 44. Global Alzheimer's Disease Drug Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 45. Global Alzheimer's Disease Drug Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 46. Market Position of Manufacturers in Alzheimer's Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 47. Head Office and Alzheimer's Disease Drug Production Site of Key Manufacturer
    Table 48. Alzheimer's Disease Drug Market: Company Product Type Footprint
    Table 49. Alzheimer's Disease Drug Market: Company Product Application Footprint
    Table 50. Alzheimer's Disease Drug New Market Entrants and Barriers to Market Entry
    Table 51. Alzheimer's Disease Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Alzheimer's Disease Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 53. Global Alzheimer's Disease Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 54. Global Alzheimer's Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 55. Global Alzheimer's Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 56. Global Alzheimer's Disease Drug Average Price by Region (2019-2024) & (USD/Unit)
    Table 57. Global Alzheimer's Disease Drug Average Price by Region (2025-2030) & (USD/Unit)
    Table 58. Global Alzheimer's Disease Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 59. Global Alzheimer's Disease Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 60. Global Alzheimer's Disease Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 61. Global Alzheimer's Disease Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 62. Global Alzheimer's Disease Drug Average Price by Type (2019-2024) & (USD/Unit)
    Table 63. Global Alzheimer's Disease Drug Average Price by Type (2025-2030) & (USD/Unit)
    Table 64. Global Alzheimer's Disease Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 65. Global Alzheimer's Disease Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 66. Global Alzheimer's Disease Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. Global Alzheimer's Disease Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. Global Alzheimer's Disease Drug Average Price by Application (2019-2024) & (USD/Unit)
    Table 69. Global Alzheimer's Disease Drug Average Price by Application (2025-2030) & (USD/Unit)
    Table 70. North America Alzheimer's Disease Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 71. North America Alzheimer's Disease Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 72. North America Alzheimer's Disease Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 73. North America Alzheimer's Disease Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 74. North America Alzheimer's Disease Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 75. North America Alzheimer's Disease Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 76. North America Alzheimer's Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 77. North America Alzheimer's Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 78. Europe Alzheimer's Disease Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 79. Europe Alzheimer's Disease Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 80. Europe Alzheimer's Disease Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 81. Europe Alzheimer's Disease Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 82. Europe Alzheimer's Disease Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 83. Europe Alzheimer's Disease Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 84. Europe Alzheimer's Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Alzheimer's Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 87. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 88. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 89. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 90. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 91. Asia-Pacific Alzheimer's Disease Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 92. Asia-Pacific Alzheimer's Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 93. Asia-Pacific Alzheimer's Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 94. South America Alzheimer's Disease Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 95. South America Alzheimer's Disease Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 96. South America Alzheimer's Disease Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 97. South America Alzheimer's Disease Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 98. South America Alzheimer's Disease Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 99. South America Alzheimer's Disease Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 100. South America Alzheimer's Disease Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 101. South America Alzheimer's Disease Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 103. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 104. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 105. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 106. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 107. Middle East & Africa Alzheimer's Disease Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 108. Middle East & Africa Alzheimer's Disease Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Alzheimer's Disease Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 110. Alzheimer's Disease Drug Raw Material
    Table 111. Key Manufacturers of Alzheimer's Disease Drug Raw Materials
    Table 112. Alzheimer's Disease Drug Typical Distributors
    Table 113. Alzheimer's Disease Drug Typical Customers
List of Figures
    Figure 1. Alzheimer's Disease Drug Picture
    Figure 2. Global Alzheimer's Disease Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Alzheimer's Disease Drug Consumption Value Market Share by Type in 2023
    Figure 4. Donepezil Examples
    Figure 5. Memantine Examples
    Figure 6. Rivastigmine Examples
    Figure 7. Others Examples
    Figure 8. Global Alzheimer's Disease Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 9. Global Alzheimer's Disease Drug Consumption Value Market Share by Application in 2023
    Figure 10. Early to Moderate Stages Examples
    Figure 11. Moderate to Severe Stages Examples
    Figure 12. Global Alzheimer's Disease Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Alzheimer's Disease Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Alzheimer's Disease Drug Sales Quantity (2019-2030) & (K Units)
    Figure 15. Global Alzheimer's Disease Drug Average Price (2019-2030) & (USD/Unit)
    Figure 16. Global Alzheimer's Disease Drug Sales Quantity Market Share by Manufacturer in 2023
    Figure 17. Global Alzheimer's Disease Drug Consumption Value Market Share by Manufacturer in 2023
    Figure 18. Producer Shipments of Alzheimer's Disease Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 19. Top 3 Alzheimer's Disease Drug Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Top 6 Alzheimer's Disease Drug Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Global Alzheimer's Disease Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 22. Global Alzheimer's Disease Drug Consumption Value Market Share by Region (2019-2030)
    Figure 23. North America Alzheimer's Disease Drug Consumption Value (2019-2030) & (USD Million)
    Figure 24. Europe Alzheimer's Disease Drug Consumption Value (2019-2030) & (USD Million)
    Figure 25. Asia-Pacific Alzheimer's Disease Drug Consumption Value (2019-2030) & (USD Million)
    Figure 26. South America Alzheimer's Disease Drug Consumption Value (2019-2030) & (USD Million)
    Figure 27. Middle East & Africa Alzheimer's Disease Drug Consumption Value (2019-2030) & (USD Million)
    Figure 28. Global Alzheimer's Disease Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 29. Global Alzheimer's Disease Drug Consumption Value Market Share by Type (2019-2030)
    Figure 30. Global Alzheimer's Disease Drug Average Price by Type (2019-2030) & (USD/Unit)
    Figure 31. Global Alzheimer's Disease Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 32. Global Alzheimer's Disease Drug Consumption Value Market Share by Application (2019-2030)
    Figure 33. Global Alzheimer's Disease Drug Average Price by Application (2019-2030) & (USD/Unit)
    Figure 34. North America Alzheimer's Disease Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 35. North America Alzheimer's Disease Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 36. North America Alzheimer's Disease Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 37. North America Alzheimer's Disease Drug Consumption Value Market Share by Country (2019-2030)
    Figure 38. United States Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Canada Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Mexico Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Europe Alzheimer's Disease Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 42. Europe Alzheimer's Disease Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 43. Europe Alzheimer's Disease Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 44. Europe Alzheimer's Disease Drug Consumption Value Market Share by Country (2019-2030)
    Figure 45. Germany Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. France Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. United Kingdom Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Russia Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Italy Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Asia-Pacific Alzheimer's Disease Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 51. Asia-Pacific Alzheimer's Disease Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 52. Asia-Pacific Alzheimer's Disease Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 53. Asia-Pacific Alzheimer's Disease Drug Consumption Value Market Share by Region (2019-2030)
    Figure 54. China Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Japan Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Korea Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. India Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Southeast Asia Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Australia Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. South America Alzheimer's Disease Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 61. South America Alzheimer's Disease Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 62. South America Alzheimer's Disease Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 63. South America Alzheimer's Disease Drug Consumption Value Market Share by Country (2019-2030)
    Figure 64. Brazil Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Argentina Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Middle East & Africa Alzheimer's Disease Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 67. Middle East & Africa Alzheimer's Disease Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 68. Middle East & Africa Alzheimer's Disease Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 69. Middle East & Africa Alzheimer's Disease Drug Consumption Value Market Share by Region (2019-2030)
    Figure 70. Turkey Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Egypt Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Saudi Arabia Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. South Africa Alzheimer's Disease Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Alzheimer's Disease Drug Market Drivers
    Figure 75. Alzheimer's Disease Drug Market Restraints
    Figure 76. Alzheimer's Disease Drug Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Alzheimer's Disease Drug in 2023
    Figure 79. Manufacturing Process Analysis of Alzheimer's Disease Drug
    Figure 80. Alzheimer's Disease Drug Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Companies Mentioned

Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck